AFORÉ™ BY DR. FEW ANNOUNCES PUBLICATION OF THE FIRST-EVER STUDY EVALUATING THE EFFECTS OF RETINOL AND CANNABIDIOL (CBD) IN TOPICAL SKINCARE
- Friday, January 28, 2022, 7:05
- Finance
- Add a comment
CHICAGO, Jan. 28, 2022 /PRNewswire/ — Aforé™ by Dr. Few, a clinically developed skincare line built around Dr. Julius Few’s innovative Four Dimensional Beauty™ philosophy, today announces the publication of the first-ever clinical study on the effects of a retinol and Cannabidiol (CBD)…
About the Author
adminasapcorp has written 39016 stories on this site.